BioSig Technologies, Inc.
BSGM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 122.2% | -93.7% | -35.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 80.1% | 54.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -31,052.5% | -156,394.4% | -9,430.8% | -7,531.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -25,825% | -161,338.9% | -9,535.3% | -7,111.6% |
| EPS Diluted | -0.074 | -0.4 | -0.63 | -0.94 |
| % Growth | 81.6% | 36.5% | 33% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |